Postprandial serum cholylglycine as a marker of antituberculous drug hepatotoxicity in HIV-infected patients.
Alegre
J
J
Fernandez de Sevilla
T
T
Falcó
V
V
Armadans
L
L
Martínez Vázquez
J M
JM
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis*; D004435:Eating; D006000:Glycocholic Acid / Q000097:blood*; D006801:Humans; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D006000:Glycocholic Acid